Personalized vaccine treatment for brain cancer patients who didn't qualify for another study
Part of Brain & nervous system, Cancer clinical trials.
This trial offers a personalized vaccine (DCVax-L) made from your own tumor cells to patients with glioblastoma (a type of brain cancer) who were not able to join a previous study. The vaccine aims to help your immune system fight the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were not eligible for the earlier study (020221) because your tumor showed signs of progression or the vaccine supply was too low.
- You need to be able to care for yourself (score of at least 70 on the Karnofsky scale).
- If you are on steroids, the dose should be reduced to 4 mg or less of dexamethasone per day before starting treatment.
- Your personalized vaccine must have been successfully made and released for use.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests ADCV01, given “on top of” other standard treatment, for newly diagnosed glioblastoma (grade 4 brain tumor). The goal is to see whether it helps patients live longer and safely manage tumor growth.
This trial tests a personalized vaccine made from your own tumor cells, given after standard treatment (surgery and chemo/radiation) for newly diagnosed glioblastoma. The vaccine aims to train your immune system to fight any remaining cancer cells.
This trial tests a personalized vaccine made from your own immune cells (a dendritic cell vaccine) that may help your body fight the brain tumor. It is meant for people with DIPG or glioblastoma who have already tried standard treatments but still have tumors.
This trial tests a vaccine made from your own immune cells to fight glioblastoma, a type of brain cancer. It may help your body attack the cancer more effectively after standard treatments.
This trial tests an experimental 'vaccine' made from your own immune cells (dendritic cells). The vaccine is designed to train your immune system to attack the brain tumor. It is for people whose glioblastoma has returned or progressed after standard treatment.
This trial tests a personalized cancer vaccine made from your own tumor, combined with standard chemotherapy and a drug that helps your immune system fight the cancer. It aims to see if this combination can improve outcomes for people with glioblastoma.
Hear when a new GBM trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.